Company Haisco Pharmaceutical Group Co., Ltd.

002653

CNE100001BC7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-08			5-day change	1st Jan Change
61.47 ^CNY	+2.13%		+2.76%	+84.87%

Nov. 03	Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial	MT
Oct. 29	Haisco Pharmaceutical's Q3 Profit Down 23%, Revenue Up 22%	MT

Business description: Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co.,Ltd., formerly Xizang Haisco Pharmaceutical Group Co., Ltd., is a China-based company principally engaged in the research, development, manufacture and sale of new drugs and high-end medical instrument. The Companyâs main products are categorized into small volume injections, big volume injections, freeze-dried powder injections and others, which include polyene phosphatidylcholine injections, lipid solubility vitamins injection series, doradiazine methanesulfonate injections, nalmefene hydrochloride injections, fluprofen tromethamine tablets and cefoperazone sodium tazobactam sodium for injections, among others. The Company distributes its products in domestic market.

Number of employees: 5,337

Sales by Activity: Haisco Pharmaceutical Group Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
Parent Company	3.1B	2.68B	2.99B	3.42B	3.17B
Consolidated Entity of Tibet Haisco Pharmaceutical	-	-	-	-	1.56B
Xichang Haisco	-	-	-	-	1.14B
Sichuan Haisco merger entity	-	-	351M	446M	812M
Liaoning Haisco	-	-	690M	947M	716M
Shenyang Haisco	-	-	24.9M	-	190M
Tibet Haize Group	-	-	1.52B	1.48B	-
Chengdu Hisco Pharmaceuticals Merged Entity	68.28M	147M	214M	308M	-
Tibet Pharmaceutical (merged)	-	-	338M	-	-
CSO Company	1.64B	1.62B	-	-	-
Other Divisions	-	9.22M	-	-	-
Hong Kong Haisco (merged)	-	36.35M	46.58M	1.44M	-
Liaohai	410M	478M	-	-	-
Chuankai	336M	571M	-	-	-
Inter-Segment Elimination	-2.23B	-2.78B	-3.17B	-3.27B	-3.89B

See all business segments

Geographical breakdown of sales: Haisco Pharmaceutical Group Co., Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
China	3.33B	2.77B	3.02B	3.36B	3.72B

See all geographic segments

Executive Committee: Haisco Pharmaceutical Group Co., Ltd.

Manager	Title	Age	Since
Xiu Lian Fan CEO	Chief Executive Officer	61	2019-03-25
Peng Duan DFI	Director of Finance/CFO	50	2016-10-20
Wei Zheng PRN	Corporate Officer/Principal	55	2006-12-31
Yan Guo IRC	Investor Relations Contact	-	-
Meng Wang IRC	Investor Relations Contact	40	2011-01-31

See HAISCO PHARMACEUTICAL GROUP CO., LTD. governance

Composition of the Board of Directors: Haisco Pharmaceutical Group Co., Ltd.

Director	Title	Age	Since
Jun Min Wang CHM	Chairman	57	2006-12-31
Wei Zheng BRD	Director/Board Member	55	2006-12-31
Xiu Lian Fan BRD	Director/Board Member	61	2006-12-31
Chuan De Cao BRD	Director/Board Member	61	2023-08-24
Jun Le BRD	Director/Board Member	54	2020-05-19
Tao Sun CHM	Chairman	42	2023-08-30

Composition of the Board of Directors

Shareholders: Haisco Pharmaceutical Group Co., Ltd.

Name	Equities	%	Valuation
Jun Min Wang 18.64 %	99,887,600	18.64 %	844 M ¥
Xiu Lian Fan 10.14 %	54,328,900	10.14 %	459 M ¥
Ping Shen 9.028 %	48,375,894	9.028 %	409 M ¥
Fei Yang 7.921 %	42,442,286	7.921 %	359 M ¥
Wei Zheng 7.191 %	38,532,075	7.191 %	326 M ¥

Name	Equities	%	Valuation
Jun Min Wang 47.01 %	299,662,800	47.01 %	2 532 M ¥
Xiu Lian Fan 25.57 %	162,986,700	25.57 %	1 377 M ¥
Wei Zheng 18.13 %	115,596,225	18.13 %	977 M ¥

List of HAISCO PHARMACEUTICAL GROUP CO., LTD. shareholders

Company details: Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd.

17 Sanxiang Avenue

856000, Shannan

+86 89 3783 4865

http://www.haisco.com

address Haisco Pharmaceutical Group Co., Ltd.(002653)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
HAISCO PHARMACEUTICAL GROUP CO., LTD.	+2.13%	+2.76%	+67.04%	+186.57%	9.44B
ELI LILLY AND COMPANY	-1.26%	-7.24%	+20.67%	+168.19%	905B
JOHNSON & JOHNSON	-0.15%	-2.56%	+35.03%	+13.80%	487B
ABBVIE INC.	-1.31%	-2.01%	+26.64%	+34.90%	400B
ROCHE HOLDING AG	+2.19%	+3.35%	+23.62%	+5.48%	330B
ASTRAZENECA PLC	-0.10%	-2.83%	+27.45%	+20.61%	281B
NOVARTIS AG	-0.41%	+2.07%	+18.74%	+24.32%	255B
MERCK & CO., INC.	-0.79%	-5.63%	-4.04%	-10.14%	248B
NOVO NORDISK A/S	-3.42%	-5.68%	-61.94%	-32.73%	214B
AMGEN INC.	-2.63%	-7.01%	+17.85%	+12.41%	178B
Average	-0.35%	-1.64%	+17.11%	+42.34%	330.6B
Weighted average by Cap.	-0.37%	-2.77%	+17.00%	+54.77%